Hospital's inpatient service paused for a month
Admissions to Kent Community Health NHS Foundation Trust's Faversham Cottage Hospital were paused on 27 June due to a rising number of nursing vacancies and sickness, particularly in critical leadership roles.
The trust later made the decision to not reopen to admissions and to temporarily stop the inpatient service while a full review of staffing was carried out.
Mairead McCormick, the trust's chief executive, said: "This is not a decision we have taken lightly. Our priority is, and always will be, the safety and wellbeing of our patients, staff and volunteers."
All other services at the hospital, which provides rehabilitation for patients, are unaffected.
Ms McCormick said: "During the past couple of months we have been working hard to bolster staffing; transferring colleagues from alternative hospitals, recruiting to vacant posts, supporting staff to return to work and using our bank and agency workforce.
"Despite these efforts, it is no longer sustainable to continue to use a temporary workforce and re-deploy staff from our other hospitals, placing other services at risk."
The trust says it will work with staff and partners to minimise disruption and offer alternative temporary roles to allow more people to receive care in their own homes or at other community hospitals.
Faversham and Mid Kent's Conservative MP Helen Whately says she is "deeply concerned" about the future of the hospital.
She added: "Of course the hospital needs to be safely staffed, but there should have been warnings to the community before now if it was at risk.
"The Cottage Hospital is an integral part of Faversham and it must reopen."
The trust, which has been contacted for more information, has committed to reviewing its decision within a month.
Follow BBC Kent on Facebook, on X, and on Instagram. Send your story ideas to southeasttoday@bbc.co.uk or WhatsApp us on 08081 002250.
New plan will fundamentally rewire NHS, says PM
NHS AI pilot aims to ease administrative burden
Hospitals in South East given £67m for repairs
Kent Community Health NHS Foundation Trust
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Versailles Hospital Center adopts digital pathology platform
The Versailles Hospital Center has begun a digital pathology transformation by selecting Tribun Health's CaloPix imaging platform. This move is a significant step in modernising the French public healthcare system's diagnostic services and integrating artificial intelligence (AI) into pathology. The implementation of CaloPix within the pathology department is set to streamline primary diagnostics and interdisciplinary collaboration. Tribun Health CEO Jean-François POMEROL said: 'This choice reflects a shared commitment to innovating for more effective, collaborative, and patient-centered healthcare.' Tribun Health's platform has a user-friendly interface and flexibility, catering to the dynamic requirements of hospital infrastructures. It is designed to be open and interoperable, allowing it to integrate with the hospital's digital strategy. This initiative is in line with the Versailles Hospital Center and GHT 78 Sud's digital objectives, which are coordinated with GHT Nord. It contributes to a national effort to upgrade and digitise healthcare facilities. Versailles Hospital Center is GHT 78 Sud's supporting institution. Versailles Hospital Center Pathology Department head Dr Claire GLASER said: 'The selection of CaloPix is fully aligned with our digital transformation strategy. We were impressed by the solution's user-friendliness, performance, and the quality of support offered by Tribun Health's teams. 'This project, developed in collaboration with the GHT Yvelines Nord, marks a key step for the future of our specialty in the region, particularly regarding AI and collaborative work. It also enhances our integration into APHP's expert networks equipped with the same software.' Tribun Health uses data-driven technology and AI to improve precision and minimise turnaround times to assist laboratories and hospitals in transitioning from glass slide pathology to complete digital solutions. "Versailles Hospital Center adopts digital pathology platform" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
22 minutes ago
- Yahoo
Modella AI and AstraZeneca link for cancer clinical development
Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The partnership will give AstraZeneca access to Modella AI's multi-modal foundation models. The agreement will enable the use of Modella AI's latest models, with rich feature extraction from different types of data, to speed up clinical development across AstraZeneca's worldwide oncology portfolio. AstraZeneca oncology research and development (R&D) chief AI and data scientist Jorge Reis-Filho stated: 'At AstraZeneca, AI is integrated across every aspect of clinical development. 'Through the use of foundation models, combined with our unique datasets and AI expertise, we are confident in our strategy to accelerate development and increase the probabilities of success in our oncology clinical trials.' AstraZeneca will use Modella AI's platform for cancer research R&D capabilities to improve biomarker discovery and clinical development while enhancing patient outcomes. By integrating these advanced foundation models into its R&D pipeline, AstraZeneca seeks to enable data-driven discovery methods with increased speed. Modella AI CEO Jill Stefanelli stated: 'Foundation models are transforming precision medicine. They are the backbone of AI-powered biomedical discovery and mark the first step toward fully autonomous AI agents. 'Our state-of-the-art multimodal foundation models provide powerful features from different data types for downstream tasks. When integrated with AstraZeneca's research engine, they will have the potential to accelerate data-driven development and enable the development of new AI agents that can automate complex R&D workflows.' In June 2025, the US Food and Drug Administration (FDA) approved AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that exhibits mutations in the epidermal growth factor receptor. "Modella AI and AstraZeneca link for cancer clinical development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
Plans for new hospital in city to meet high demand
Plans have been submitted by a developer to build a new city hospital for day patients to tackle a "continued increase" in waiting times. Thorpe Wood Hospital in Peterborough would be part of the private hospital group, Ramsay Health Care UK, which already runs the Fitzwilliam Hospital in the city. In a report submitted to Peterborough City Council, developers ELG said the project would help to manage "excessive demand in the local health system". It said the Fitzwilliam had already "reached capacity", adding: "Essential expansion is urgently required for day case and community diagnostics." It said: "This investment is seen as being important and intrinsic to reducing the continued increase in patient waiting times and deferred treatment and diagnostic services in the community." There would be on-site magnetic resonance imaging (MRI) facilities and computed tomography (CT) scanners for early diagnostic and surgical intervention. This would allow the Fitzwilliam to have more bed capacity for procedures such as complex surgeries. The new facility would be dedicated to several different areas including general surgery, ophthalmology, urology and gynaecology. The report said there was a "huge task" of clearing a backlog of NHS patients waiting for treatment, which has led to private hospitals taking on the care of some NHS patients. It is estimated 142 members of staff would work at the hospital, caring for patients coming via the private sector as well as the NHS. The single-storey hospital building is planned for a business park on the western edge of Peterborough. The plans have yet to be considered by Peterborough City Council. Follow Peterborough news on BBC Sounds, Facebook, Instagram and X. Plan to convert church hall into homes submitted Safety measures to be introduced at busy junction Former reptile pet shop to become pizza takeaway Peterborough City Council Planning Register
